Introduction
IVV compartment, the so called 'refill'. The balance between UF and refill has major influence on the IVV. Symptomatic hypotension is a common problem in
The more efficient the refill in proportion to UF, the haemodialysis treatment. It seriously impairs the state more constant the IVV will be maintained. The main of well-being of the patients and it may induce severe factors that influence the refill are listed in Table 1 . cardiac arrhythmias. Despite profound improvements When refill lags behind ultrafiltration, other comof haemodialysis technique in recent years the frepensatory mechanisms are required to maintain blood quency of recurrent intradialytic hypotensive episodes pressure. In this context cardiac output, systemic vascuhas remained nearly unchanged (occurring in approxilar resistance (SVR) or both may increase to keep up mately 20-30% of all HD sessions [1] ). Because of the perfusion pressure. There is a sequence of regulatory increasing age of today's dialysis patients and because mechanisms that increases arterial and venous vascular of the growing prevalence of diabetic end-stage kidney tone in response to IVV diminution (extensively disease, this problem is likely to become even more reviewed in [2] ). These mechanisms are listed in important in the future. Table 2 . Sympathetic activation increases heart rate From a clinical point of view one may consider two and contractility. However these effects are not very groups of subjects susceptible to dialysis hypotension: efficient in blood pressure defence, since their gain is (i) A larger group of basically normotensive or hyper-limited by venous return. The latter is usually reduced tensive patients who are prone to intradialytic in states of deficient vascular refill. decreases in systolic blood pressure of 30 mmHg Based on these physiological considerations four or more, resulting in symptomatic hypotension. pathophysiological conditions predisposing to intradiaPatients in this group are often diabetics or have lytic hypotension have been intensively investigated: advanced left ventricular hypertrophy causing dia-(i) insufficient refill, (ii) autonomic dysfunction, (iii) stolic dysfunction.
left ventricular diastolic dysfunction, and (iv) imbal-(ii) A smaller group of patients with sustained hypoten-ance of vasoactive agents.
sion that also persists throughout the interdialytic interval. This group usually includes anephric patients and those that have been on haemodialysis Plasma refill for many years. The systolic blood pressure of these patients will rarely exceed 100 mmHg. A modest Plasma refill is important for cardiovascular stability reduction in blood pressure triggered by ultrafiltra-during haemodialysis treatment. Its extent determines tion will suffice to cause symptomatic hypotension. the gain of neurohumoral compensation. Typical pathophysiological conditions that impair the refill are This contribution is an attempt to develop diagnostic listed in Table 3 . It is paramount to realize that depleand therapeutic strategies for the prevention of dialysis tion of interstitial volume due to dry-weight error is hypotension on the basis of the-incompletely understood-pathophysiology of hypotension in dialysis patients. in selected patients; however, at the present time any
Active venoconstriction?
such patients have to be identified by trial and error. Finally, it is interesting that isolated UF as well as techniques providing a high convective solute transport 
Left ventricular diastolic dysfunction (LVDD)
the most common cause of intradialytic hypotension.
To assess this possibility one should resort to an objective method of measurement of the state of hydra-Approximately 70% of the dialysis population shows left ventricular hypertrophy [9] . The latter is typically tion (e.g. echocardiography and sonography of the inferior vena cava or measurement of tissue imped-associated with marked diastolic dysfunction. The genesis of left ventricular hypertrophy is multifactorial, ance). Several authors could clearly demonstrate that volume-depleted patients experience a significantly and factors other than preceding hypertension also play a role, for example anaemia, hyperparathyroidmore pronounced decline in IVV in response to a given amount of UF than do normovolaemic or hypervol-ism, and impaired aortic compliance. Such patients usually have concentric left ventricular hypertrophy aemic patients [3, 4] . In addition to dry weight the total amount and the rate of UF play important roles and elevated left ventricular enddiastolic pressure (LVEDP) with reduced ventricular compliance. In for intradialytic hypotension. For instance, both a high interdialytic weight gain and a short treatment time contrast to this, systolic left ventricular function is usually preserved. The diastolic dysfunction does not usually result in more aggressive UF, which in turn will be followed by an imbalance of the UF/refill ratio cause hypotension per se, rather it is a factor that decreases tolerance to ultrafiltration. A patient with even in normovolaemic patients. Attempts to improve the refill in such circumstances have been made using LVDD subjected to inadequate refill in response to UF will probably experience a significant reduction in UF profiling. Recommended protocols usually propose cardiac output. This will occur more readily than in a a paradoxical withdrawal of sympathetic drive in their studies. The result was vasodepressor syncope with patient without LVDD, because in the former case stroke volume depends more strongly on the elevated bradycardic hypotension. However, this mechanism cannot account for all hypotensive episodes, since most LVEDP than it does in the latter. In other words, even a mild reduction in venous return, tolerable to a patient intradialytic hypotensive episodes will be accompanied by tachycardia [15] . Bradycardic hypotension seems with normal diastolic function, results in a marked decrease in cardiac output and blood pressure in a to be more a product of severe cardiac underfilling than of sympathetic impairment. The dialysis procedpatient with LVDD. The blood pressure drop in patients with LVDD often will be sudden and pro-ure itself appears to have no appreciable effect on autonomic function [16 ] . nounced. Furthermore, in this situation an increase in heart rate may not compensate for the drop in cardiac As first shown by Elias et al.
[17], chronic uraemia is associated with elevated plasma catecholamine levels. filling, because the associated shortening of diastolic filling time will diminish stroke volume. These events This change is attributable to early impairment of the afferent parasympathetic baroreflex arc and may eventually lead to a dramatic decrease of venous return, resulting in cardiac emptying. This chain of to decreased renal clearance of catecholamines. In response to both increased levels of catecholamines events may lead to paradoxical bradycardia via the Bezold-Jarisch reflex.
and an elevated basal sympathetic tone [14] , there is downregulation of adrenoceptors in the cardiovascular In a study by Ruffmann et al. [10] , diastolic function in patients prone to intradialytic hypotension was system causing impaired responsiveness to sympathetic stimuli [18] . This phenomenon is typically present in significantly more 'dysfunctional' than in a group of stable HD patients.
persistently hypotensive patients with low tolerance to ultrafiltration [13] . The cardiac emptying may explain the brisk response of such patients to rapid volume supplementation. The
Taken together, some degree of autonomic dysfunction as well as of diminished responsiveness to symlatter will readily improve venous return and thereby re-establish an adequate left ventricular filling. On the pathetic stimuli seems to play a role both in patients with frequent hypotensive episodes and in persistently other hand, patients with LVDD are also very susceptible to volume overload. This can result in a rapid rise hypotensive subjects. At the present time a reliable therapy for autonomic impairment is lacking. Howof blood pressure and in cardiac 'backward failure', causing pulmonary oedema.
ever, there are two helpful manoeuvres to augment blood redistribution to central compartments. They Taken together, correct assessment of dry weight is essential to the management of patients with LVDD. are: (i) cool dialysis using a dialysate temperature of about 35°C (reviewed in [19]), and (ii) avoidance of Only modest interdialytic weight gain should be adhered to by the patient. Long-term treatment with food intake during the HD session. Not all patients may tolerate cool HD, however. The negative effect of an ACE inhibitor may be tried for reduction of left ventricular hypertrophy even in the absence of overt food intake on haemodynamics during HD seems to be more pronounced in the presence of advanced hypertension. In addition the nephrologist should guide the UF judiciously and individually during the dialysis autonomic neuropathy [20] .
Midodrine, a sympathicomimetic drug has been used procedure.
by practising nephrologists against dialysis hypotension for a long time. Recently midodrine was shown
Autonomic dysfunction
to be effective in improving cardiovascular stability during HD in 10 hypotension-prone patients [21] . Increasing sympathetic activity is an integral part of the neurohumoral response to UF. This reaction
Role of endogenous vasoactive systems
is initiated by the cardiopulmonary and pressoreceptor reflex arc. It results in blood redistribution from skin and splanchnic circulations to central Numerous studies have looked into the possibility of an imbalance between vasoconstricting and vasodilatcompartments.
Uraemia is associated with autonomic dysfunction, ing endogenous agents as a cause of dialysis hypotension. Investigating this issue is complicated. Most demonstrable even in early states of renal insufficiency [11] . Numerous studies have been performed to clarify endogenous vasoactive compounds are part of a complex network of regulating factors. In defining the role the role of impaired autonomic function in dialysis hypotension.
of an individual agonist, one has to consider not only its plasma concentration, but also the level of any Using different autonomic function tests, most authors reported parasympathetic dysfunction. In per-possible endogenous antagonist, the receptor density and the biological response to this setting of agonist/ sistently hypotensive HD patients this was accompanied by sympathetic impairment [12, 13] . These patients antagonist that is present.
Moore et al. [22] demonstrated higher plasma levels are not able to increase heart rate and/or systemic vascular resistance adequately in response to UF [14] . of renin (PRA), angiotensin II (AII ), and aldosterone in persistently hypotensive HD patients than in normoContinuous registration of sympathetic nerve activity in hypotension prone HD patients during UF showed tensive HD patients. There was a blunted response to pressor dose infusions of AII in hypotensives. This
The roles of calcitonin-gene-related peptide (CGRP), adrenomedullin, atrial natriuretic peptide, prostawas attributed to decreased AII-receptor density. Similar results were reported by Esforzado Armengol glandins, and other vasodilators in the blood pressure regulation of HD patients have not received a great et al. [13] . In their study PRA and AII-levels were highest in the hypotensive HD patients. Corresponding deal of attention and could not be conclusively clarified. Odar-Cederlof et al. [31] reported a continuous results have also been reported for plasma catecholamines (see above in the section on autonomic rise of CGRP plasma levels during isovolaemic HD.
However, the relevance of this finding for dialysis dysfunction).
In contrast, anephric patients show significantly hypotension is presently unknown. lower PRA and AII plasma levels than do those with kidneys present. The fact that PRA and AII is low but Prediction of hypovolaemic episodes not completely absent in anephric patients is usually attributed to extrarenal generation of these compounds. The levels of PRA and AII do not increase in An interesting approach to the prediction of hypotensive episodes is the continuous monitoring of the IVV. response to volume depletion [23] . This may explain, why some anephric patients are persistently hypotens-Such methods may be important because they show the balance between UF and refill. ive and/or have a poor tolerance to UF.
In summary, there seems to be a reduced vascular Several approaches for measuring the IVV have been developed in the past. One method uses the continous response to catecholamines and to AII in persistently hypotensive HD patients. This lack of vascular registration of haematocrit or haemoglobin concentration in the extracorporeal circuit. This method requires responsiveness may contribute to their sustained low blood pressure and reduced tolerance to ultrafiltration. that the red-cell mass remains unchanged during treatment. Whether this is true also for other vasopressors like endothelin-1, arginine vasopressin, or thromboxane A2
Kim et al. [32] were the first to investigate the relationship between reduction of IVV (as measured is not known at present.
Recently several studies focused on the role of nitric by a dilution technique) and hypotension during dialysis. In their study, approximately 80% of hypotensive oxide (NO). This agent is a potent vasodilator. It is conceivable in principle that NO could contribute to episodes were predicted by a reduction of IVV below a threshold of 50 ml/kg body mass. Similar results dialysis hypotension. Based on the interleukin hypothesis, Beasley and Brenner [24] proposed that dialysis were obtained by Steuer et al. [33] . By continuously monitoring the haematocrit they clearly demonstrated causes induction of NO-synthase (iNOS, NOS II ). This would result in sustained NO 'overproduction' an association between intradialytic morbid events (hypotension, cramping, nausea) and hypovolaemia. and possibly hypotension. There is evidence indeed to show an association of end stage renal failure with In particular there was an individually defined threshold value for the haematocrit at which hypotension elevated plasma levels of NO-related compounds [25, 26 ] . However patients on peritoneal dialysis became predictable. By manipulating the UF rate in such a way that the haematocrit threshold value was showed similar levels [25] . Measurement of native NO in biological fluids is technically difficult if not imposs-avoided (increasing UF when haematocrit was low; decreasing UF when haematocrit was approaching the ible at present. It is therefore unclear whether those NO related compounds actually represent the haemo-threshold ), they were successful at reducing hypovolaemic symptoms by 50%. This was accomplished withdynamically active NO pool [27] . Moreover there is evidence of uraemia-associated endogenous NOS out prolongation of treatment time. Moreover these and other authors [3] found, that hypotension was inhibitors (ADMA, [28] ). They may be of major importance in terms of NO effectiveness and blood-predicted by an accelerated IVV reduction in the 10 min immediately prior to the event. However, other pressure regulation. We showed recently that infusion of L-NMMA (a blocker of NOS) into the brachial authors could not reproduce this particular observation [34] . artery of normotensive HD patients and controls results in a similar reduction of forearm blood flow in
The concept of a threshold haematocrit is an attractive one because of its conceptual relation to an both groups [29] . This result suggests that NO participates in the regulation of vascular tone in normotensive individual blood volume at which neurohumoral mechanisms will fail to maintain an adequate blood pressure. HD patients and healthy controls alike.
A related question may have to do with sterile To deal with such an individual threshold, however, a computerized, IVV-controlled regulation of the UF dialysate. It is possible that sterile dialysate would improve cardiovascular stability by reducing cytokine would appear to be promising. Using an automated system that guides the intradialytic IVV along a prerelease. Van Kuijk et al. [30] treated 10 HD patients with either sterile or unsterile dialysate in a cross-over defined trajectory, Mancini et al. [35] recently demonstrated a considerable reduction of intradialytic study. They found no significant differences in blood pressure, heart rate, forearm vascular resistance, and hypotensive episodes compared to standard HD in five hypotension-prone HD patients. None the less there venous tone. These results may suggest that the use of sterile dialysate has little if any influence on vascular are still several unresolved issues. Bleeding, erythropoietin therapy, recirculation in the fistula, or changes reactivity during HD. 
